Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for METOLAZONE
- Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload
- Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance
- The Heart Failure Diuresis Efficacy Comparison (DEA-HF) Study
- Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure
- Lokelma for RAAS Maximisation in CKD & Heart Failure.
- DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance
- Efficacy of Diuretics in Kidney Disease
- Ertugliflozin in Acute Heart Failure
- Sequential Nephron Blockade in Acute Heart Failure
- Safety and Efficacy of Early, seQUential Oral dIuretic Nephron blockAde In Acute Heart Failure
- Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
- Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance
- AiDing Diuresis wIth Tolvaptan (ADD-IT)
- Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.
- Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
- A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)
- Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis
- Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload
- Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure
- A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients
- Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg
- Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg
- Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg
- Hypertension Screening and Treatment Program
Clinical trials list
click for details